PharmaSGP

PharmaSGP

PSG.DE
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Overview

PharmaSGP is a publicly traded German pharmaceutical company with a mission to provide effective self-medication solutions through established OTC brands. Its primary achievement is building a profitable, focused portfolio in pain and dermatology within its core German market. The company's strategy centers on the development, marketing, and sale of these branded OTC products, managing them from inception through commercialization. This approach aims to deliver reliable performance in the competitive consumer healthcare sector.

Pain ManagementDermatology

Technology Platform

Advanced OTC formulation and lifecycle management platform focused on drug delivery optimization, consumer-centric design, and regulatory strategies for OTC switches.

Funding History

1
IPOUndisclosed

Opportunities

The large and stable German OTC market provides a solid foundation for growth.
Opportunities exist in expanding geographically within Europe and executing successful Rx-to-OTC switch projects to add new growth drivers to the portfolio.

Risk Factors

High geographic concentration in Germany and reliance on a small portfolio of mature OTC brands create significant commercial and operational risks.
Intense competition from global players and private labels pressures market share and pricing.

Competitive Landscape

Competes against global OTC giants (Bayer, Haleon) and regional peers in the crowded German consumer healthcare market. Its position relies on deep local expertise, focused branding, and agility rather than scale.